Correction: Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1636315/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849434054895599616 |
|---|---|
| author | Jiazhen Jiang Qian Zhong Xinyu Zhou Lisi Zhou Jiyuan Zheng Bingshuo Liu Xingwei Di |
| author_facet | Jiazhen Jiang Qian Zhong Xinyu Zhou Lisi Zhou Jiyuan Zheng Bingshuo Liu Xingwei Di |
| author_sort | Jiazhen Jiang |
| collection | DOAJ |
| format | Article |
| id | doaj-art-61ae1fec2a6142ca89cbc364919b6f37 |
| institution | Kabale University |
| issn | 2297-055X |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Cardiovascular Medicine |
| spelling | doaj-art-61ae1fec2a6142ca89cbc364919b6f372025-08-20T03:26:48ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2025-06-011210.3389/fcvm.2025.16363151636315Correction: Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting systemJiazhen Jiang0Qian Zhong1Xinyu Zhou2Lisi Zhou3Jiyuan Zheng4Bingshuo Liu5Xingwei Di6The First Clinical Medical School of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, ChinaDepartment of Cardiovascular Medicine, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, ChinaThe First Clinical Medical School of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, ChinaClinical Medical College of Acupuncture, Moxibustion and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, ChinaThe First Clinical Medical School of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, ChinaThe Fifth Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong,ChinaDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong,Chinahttps://www.frontiersin.org/articles/10.3389/fcvm.2025.1636315/fullamlodipineadverse drug reactionsFDA adverse event reporting systemrisk signal detectionlogistic regression |
| spellingShingle | Jiazhen Jiang Qian Zhong Xinyu Zhou Lisi Zhou Jiyuan Zheng Bingshuo Liu Xingwei Di Correction: Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system Frontiers in Cardiovascular Medicine amlodipine adverse drug reactions FDA adverse event reporting system risk signal detection logistic regression |
| title | Correction: Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system |
| title_full | Correction: Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system |
| title_fullStr | Correction: Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system |
| title_full_unstemmed | Correction: Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system |
| title_short | Correction: Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system |
| title_sort | correction adverse events associated with amlodipine a pharmacovigilance study using the fda adverse event reporting system |
| topic | amlodipine adverse drug reactions FDA adverse event reporting system risk signal detection logistic regression |
| url | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1636315/full |
| work_keys_str_mv | AT jiazhenjiang correctionadverseeventsassociatedwithamlodipineapharmacovigilancestudyusingthefdaadverseeventreportingsystem AT qianzhong correctionadverseeventsassociatedwithamlodipineapharmacovigilancestudyusingthefdaadverseeventreportingsystem AT xinyuzhou correctionadverseeventsassociatedwithamlodipineapharmacovigilancestudyusingthefdaadverseeventreportingsystem AT lisizhou correctionadverseeventsassociatedwithamlodipineapharmacovigilancestudyusingthefdaadverseeventreportingsystem AT jiyuanzheng correctionadverseeventsassociatedwithamlodipineapharmacovigilancestudyusingthefdaadverseeventreportingsystem AT bingshuoliu correctionadverseeventsassociatedwithamlodipineapharmacovigilancestudyusingthefdaadverseeventreportingsystem AT xingweidi correctionadverseeventsassociatedwithamlodipineapharmacovigilancestudyusingthefdaadverseeventreportingsystem |